Calls Grow to Re-examine B.C. Property Tax Exemptions
Millions in annual property tax exemptions spark calls for review in British Columbia. Learn about the growing pressure to reconsider who gets breaks and for how much.
Category : Search result: pharmaceutical revenue
Barbados Launches US$200M Life Sciences Hub
Barbados partners with EarlyHealth Group to build a US$200 million life sciences hub, positioning the island as the Caribbean's premier pharmaceutical and research centre.
Bad Bunny Dominates Latin Grammys with 5 Awards
Puerto Rican star Bad Bunny and Argentine duo Ca7riel & Paco Amoroso each won five Latin Grammy awards, highlighting Latin music's growing cultural impact ahead of Bad Bunny's groundbreaking Super Bowl performance.
Disney Q4 2025: Streaming & Parks Shine
The Walt Disney Company reports a strong fourth quarter driven by streaming services and theme parks, while traditional TV networks face challenges. Discover the key financial results.
Loblaw Q3 profit and revenue up year-over-year
Loblaw Companies Ltd. reports increased Q3 profit and revenue, demonstrating resilience in Canada's competitive grocery and drugstore retail sector. Learn how the retail giant is navigating economic pressures.
AI Firm Nebius Signs $3B Meta Deal, Revenue Up 400%
Nebius AI cloud company announces groundbreaking $3 billion partnership with Meta while reporting explosive revenue growth. Discover how this deal reshapes Canada's tech landscape.
Cineplex's surprise premieres boost revenue: analyst
Retail analyst reveals how Cineplex's surprise movie premieres create an 'interesting business model' that could significantly increase theater revenue through enhanced concession sales.
Pfizer wins $10B obesity drug takeover battle
Pfizer triumphs in dramatic $10 billion bidding war for obesity drug maker Metsera, securing crucial White House-backed deal to compete in weight-loss market. Read the full story.
Nova Leap Health Posts Record Q3 2025 Results
Nova Leap Health Corp announces historic financial performance with record revenue and profitability, marking the strongest quarter in company history with impressive year-over-year growth.
Trump's Plan to Slash Obesity Drug Prices
Former President Donald Trump unveils ambitious strategy to dramatically reduce costs of groundbreaking weight-loss medications, promising relief for millions struggling with obesity.
eXp World Holdings Soars with 23% Revenue Growth in Q3 2025
eXp World Holdings delivers explosive Q3 2025 results with 23% revenue surge to $1.1 billion. Discover how this cloud-based real estate powerhouse is revolutionizing the industry globally.
Montreal STM strike causes monthly pass sales decline
Montreal's public transit system faces revenue crisis as monthly pass purchases drop significantly following recent STM strike, forcing commuters to find new ways to navigate the city.
Trump's Drug Price Plan Backfires, Helps Democrats
Former President Trump's proposal to regulate Medicare drug prices faces unexpected consequences as Democrats leverage it to attack Republican positions on healthcare, creating political turmoil.
Trump Reveals Deal to Lower Obesity Drug Costs
Former President Donald Trump reveals groundbreaking agreement with pharmaceutical giant to make obesity drugs more affordable and accessible across the United States.
BCE's Ziply Acquisition Boosts Revenue Prospects
Bell Canada's parent company BCE makes bold move into U.S. fiber market with Ziply acquisition, positioning for significant revenue growth and competitive advantage in broadband expansion.
Canada Goose Q2 Loss Despite Revenue Growth
Canadian luxury outerwear giant Canada Goose reports surprising second-quarter loss despite 1% revenue increase to $281.1 million, as the company navigates wholesale challenges and invests in future growth strategies.
TC Energy Q3 Profit Dips to $841M, Revenue Rises
Canadian energy giant TC Energy reports mixed Q3 2023 results with profit declining to $841 million while revenue surges to $3.94 billion. Discover how major projects and strategic moves are shaping the company's future.
Bombardier Soars Past Q1 Revenue Expectations
Canadian aerospace giant Bombardier delivers impressive Q1 2024 results, exceeding revenue forecasts through increased service revenue and business jet deliveries.
Trump Obesity Drug Deal Boosts Pharma Stocks
Major pharmaceutical giants Novo Nordisk and Eli Lilly experience significant stock surges as former President Donald Trump considers a groundbreaking obesity drug partnership, potentially revolutionizing weight loss treatment accessibility.
Bombardier Quarterly Revenue Jumps 11% on Strong Demand
Canadian aerospace giant Bombardier reports strong Q1 2024 results with 11% revenue growth, boosted by increased service revenue and aircraft deliveries despite supply chain challenges.
Shopify Revenue Jumps 23% as Merchant Sales Soar
Canadian e-commerce giant Shopify reports impressive Q1 2024 results with 23% revenue surge and $60 billion in merchant sales, signaling strong retail recovery.
Pharma Veteran Dr. Andreas Wallnofer Joins Optigo Board
Optigo Biotherapeutics strengthens leadership with renowned pharmaceutical expert Dr. Andreas Wallnofer joining its Board of Directors as the company progresses toward Investigational New Drug (IND) enabling studies.
Kimberly-Clark Buys Kenvue in $32B Deal
In a landmark move shaking up the consumer products industry, Kimberly-Clark completes acquisition of Kenvue, forming a powerhouse expected to generate $32 billion in annual revenue.
Snap Warns November Government Shutdown Could Hit Ad Market
Snap Inc. warns investors that a looming November government shutdown could severely impact the social media advertising landscape, creating uncertainty for tech companies reliant on digital marketing revenue.
Top FDA Drug Official Resigns Amid Federal Probe
The FDA's principal deputy commissioner, Dr. Namandjé Bumpus, resigns following federal probe into undisclosed concerns about her conduct, marking significant leadership shakeup.
Ardena Appoints Chief Quality and Information Officers
Ardena strengthens its leadership with strategic hires of Chief Quality Officer and Chief Information Officer to drive operational excellence and digital transformation in pharmaceutical services.
Kimberly-Clark Buys Tylenol Maker in $48.7B Deal
In a landmark move reshaping the consumer healthcare landscape, Kimberly-Clark announces its acquisition of Kenvue, the company behind Tylenol and other household brands, in a staggering US$48.7 billion transaction that creates a new industry powerhouse.
Kimberly-Clark Buys Tylenol Maker Kenvue for $4.87B
In a landmark healthcare deal, Kimberly-Clark acquires Kenvue, the consumer health giant behind Tylenol, Band-Aid and Listerine, reshaping the North American healthcare landscape.
Toronto Mayor Revives Controversial Municipal Sales Tax Plan
Toronto Mayor Olivia Chow faces mounting criticism as she revives plans for a municipal sales tax that could significantly impact residents' wallets and the city's economic competitiveness.
Blood Pressure Medication Recall Over Cancer Risk
Health Canada issues urgent recall for specific blood pressure medications containing potentially carcinogenic nitrosamine impurity. Learn which lots are affected and what steps to take.
Page 3 of 4